These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18391115)

  • 61. Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?
    van der Wall EE; Schuijf JD; Jukema JW; Bax JJ; van der Laarse A
    Int J Cardiovasc Imaging; 2009 Feb; 25(2):141-4. PubMed ID: 19058028
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).
    Lederman RJ; Raylman RR; Fisher SJ; Kison PV; San H; Nabel EG; Wahl RL
    Nucl Med Commun; 2001 Jul; 22(7):747-53. PubMed ID: 11453046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits.
    Van Herck JL; De Meyer GR; Martinet W; Salgado RA; Shivalkar B; De Mondt R; Van De Ven H; Ludwig A; Van Der Veken P; Van Vaeck L; Bult H; Herman AG; Vrints CJ
    Basic Res Cardiol; 2010 Jan; 105(1):51-9. PubMed ID: 19693628
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.
    Cuadrado I; Saura M; Castejón B; Martin AM; Herruzo I; Balatsos N; Zamorano JL; Zaragoza C
    Expert Rev Mol Med; 2016 Apr; 18():e6. PubMed ID: 27056676
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Positron emission tomography in the diagnosis of atherosclerotic plaques in cancer patients].
    Sergienko VB; Panchkovskaia EV; Manukova VA; Rudas MS
    Ter Arkh; 2010; 82(4):45-8. PubMed ID: 20481215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).
    Rudd JH; Myers KS; Sanz J; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):379-88. PubMed ID: 18025992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determinants of FDG uptake in atherosclerosis.
    Buettner C; Rudd JH; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1302-4. PubMed ID: 22172787
    [No Abstract]   [Full Text] [Related]  

  • 68. Imaging inflammation in atherosclerosis another step forward.
    Shah PK
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1223-5. PubMed ID: 19833313
    [No Abstract]   [Full Text] [Related]  

  • 69. Arterial wall cholesterol content is a predictor of development and severity of arterial thrombosis.
    Ma H; Aziz KS; Huang R; Abela GS
    J Thromb Thrombolysis; 2006 Aug; 22(1):5-11. PubMed ID: 16786227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vascular FDG uptake: further steps toward clinical acceptance.
    Bengel FM
    J Nucl Cardiol; 2008; 15(2):154-6. PubMed ID: 18371583
    [No Abstract]   [Full Text] [Related]  

  • 71. Hybrid positron detection and optical coherence tomography system: design, calibration, and experimental validation with rabbit atherosclerotic models.
    Piao D; Sadeghi MM; Zhang J; Chen Y; Sinusas AJ; Zhu Q
    J Biomed Opt; 2005; 10(4):44010. PubMed ID: 16178644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model.
    Meng L; Lv B; Zhang S; Yv B
    Heart; 2008 Jun; 94(6):777-80. PubMed ID: 17947363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Small animal positron emission tomography imaging and in vivo studies of atherosclerosis.
    Hag AM; Ripa RS; Pedersen SF; Bodholdt RP; Kjaer A
    Clin Physiol Funct Imaging; 2013 May; 33(3):173-85. PubMed ID: 23522010
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography.
    Hyafil F; Cornily JC; Feig JE; Gordon R; Vucic E; Amirbekian V; Fisher EA; Fuster V; Feldman LJ; Fayad ZA
    Nat Med; 2007 May; 13(5):636-41. PubMed ID: 17417649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Noninvasive detection of experimental vulnerable atherosclerotic plaques with 99Tc m labeled C2A domain of synaptotagmin I].
    Fang W; Ji SD; Wang F; Yang MF; Lü B; Liu L; Wang ZZ; He ZX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):178-81. PubMed ID: 17445418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
    Rudd JH; Narula J; Strauss HW; Virmani R; Machac J; Klimas M; Tahara N; Fuster V; Warburton EA; Fayad ZA; Tawakol AA
    J Am Coll Cardiol; 2010 Jun; 55(23):2527-35. PubMed ID: 20513592
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [(18)F]-fluorodeoxyglucose. A new imaging modality for atherosclerotic plaque thrombogenicity.
    Kaikita K; Ogawa H
    Circ J; 2013; 77(10):2479-80. PubMed ID: 23986026
    [No Abstract]   [Full Text] [Related]  

  • 79. Assessment of aortic root inflammation in a patient with systemic vasculitis using F-18 FDG positron emission tomography.
    Ha JW; Lee JD; Chang BC; Chung N
    Heart; 2006 Dec; 92(12):1789. PubMed ID: 17105882
    [No Abstract]   [Full Text] [Related]  

  • 80. Monitoring plaque composition: is it worthwile?
    van der Laarse A; van der Wall EE
    Int J Cardiovasc Imaging; 2009 Mar; 25(3):259-61. PubMed ID: 19037748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.